Pharmafile Logo
Pharmafocus logo
Advanced Search

RDIF & Stelis Biopharma to supply 200 million doses of the Sputnik V vaccine

March 19, 2021
Medical Communications COVID-19, Russia, Vaccine

The Russian Direct Investment Fund (RDIF) and Stelis Biopharma have today announced a partnership which aims to produce and supply …

News

NICE recommends new triple therapy for multiple myeloma patients

March 19, 2021
Medical Communications NHS England, NICE, oncology

A new second line triple therapy is to be offered to NHS patients in England with multiple myeloma, following a …

News

AstraZeneca COVID-19 vaccine deemed “safe and effective” by EMA

March 19, 2021
Medical Communications AstraZeneca, COVID-19, EMA, Vaccine

AstraZeneca’s COVID-19 vaccine has been cleared for continued use by the EMA following an investigation into the reports of 37 …

News

AstraZeneca & MSD ovarian cancer drug combination approved by NICE

March 19, 2021
Medical Communications AstraZeneca, MSD, NICE, oncology

A new precision drug combination, olaparib with bevacizumab, will now be available on the Cancer Drugs Fund (CDF) for ovarian …

News

Antion launch new technology for cancer and tumour treatments

March 18, 2021
Cancer, action, blood cancer, myeloma

Antion Biosciences has launched a new T-cell technology platform to help with the development of new curative therapies for diseases …

News
gsk_boronia_australia

GSK starts Phase III study for severe asthma treatment

March 18, 2021
GSK, asthma, phase III

GSK has announced today that the first patient has been dosed in part of their Phase III clinical trial investigating …

News

Florida woman gives birth to first-known baby born with COVID-19 antibodies

March 18, 2021
COVID-19, Moderna, Vaccine

A woman from Florida has given birth to the first-known baby born with COVID-19 antibodies, according to findings recently published …

News
index_ph001

NICE recommends Daiichi Sankyo’s cholesterol-lowering treatments for NHS England use

March 18, 2021
Daiichi Sankyo, NICE, cholesterol

NICE has recommended Daiichi Sankyo’s bempedoic acid and bempedoic acid/ezetimibe for treating primary hypercholesterolaemia (heterozygous familial and non-familial) or mixed …

News

AstraZeneca leukaemia treatment recommended for NHS use

March 18, 2021
AstraZeneca, NHS

AstraZeneca has announced today that its oral targeted cancer therapy, Calquence (acalabrutinib), has been recommended by NICE for routine use …

News
covid-19 virus

Pharmafile.com’s weekly COVID-19 news round-up

March 17, 2021
Research and Development COVID-19, covid-19 roundup, news roundup

The past week has seen a mix of good and bad COVID-19 news; the Oxford-AstraZeneca vaccine rollout has halted throughout …

News
Eli Lilly building

Lilly’s ulcerative colitis treatment meets all key endpoints in Phase III trial

March 17, 2021
Research and Development Eli Lilly, Phase III trial, lilly, mirikizumab, ulcerative colitis

Eli Lilly’s mirikizumab treatment for ulcerative colitis (UC) patients has met the primary endpoints and all key secondary endpoints in …

News

Axol Bioscience and CENSO Biotechnologies enter merger agreement

March 17, 2021
Research and Development Axol Bioscience, Censo Biotechnologies, immune cell, merger, neuroscience

Axol Bioscience, an established provider of iPSC-derived cells, media, and characterisation services, and CENSO Biotechnologies, a cell biology CRO focused …

News

PEP-Therapy and Institut Curie’s cancer drug trial approved in France

March 17, 2021
Research and Development Cancer, France, Pep-therapy

PEP-Therapy and Institut Curie have been granted approval from the French National Agency for Medicines and Health Products (ANSM) to …

News

Medicago & GSK start plant-derived COVID-19 vaccine trial

March 17, 2021
Research and Development COVID-19, GSK

Medicago and GSK have announced the start of Phase III clinical testing of Medicago’s plant-derived COVID-19 vaccine. The vaccine candidate …

News
Janssen sign

Johnson & Johnson’s arthritis drug shows promising results in Phase III trial

March 16, 2021
Manufacturing and Production Janssen, Johnson & Johnson, PSA, Tremfya, arthritis

Johnson & Johnson’s TREMFYA treatment for active Psoriatic Arthritis (PsA) has returned positive results in its Phase III trial.

News

Roche and PTC’s SMA treatment shows positive trial results

March 16, 2021
Manufacturing and Production PTC, PTC Therapeutics, Roche, sma, spinal muscular atrophy

Roche and PTC Therapeutics’s Evrysdi treatment for children and adults with Type 2 or Type 3 spinal muscular atrophy (SMA) …

News
az

AstraZeneca vaccine suspended in 11 European countries

March 16, 2021
Manufacturing and Production AstraZeneca

Blood clot fears have caused 11 European countries to suspend the use of the Oxford-AstraZeneca vaccine. France, Germany, Italy, and …

News
gilead-sciences

Gilead and MSD partner to develop and commercialise two-drug HIV regimen

March 16, 2021
Manufacturing and Production Gilead, HIV, MSD

Gilead and MSD, known as Merck in the US and Canada, have entered into an agreement to co-develop and co-commercialise …

News

Perception and Otsuka enter collaboration and licensing deal for depression drug candidate

March 16, 2021
Manufacturing and Production CNS, Otsuka Pharmaceutical, Perception Neuroscience, depression

Perception Neuroscience and Otsuka Pharmaceutical have announced a collaboration and licensing agreement for the development and commercialisation of Perception’s lead …

News
A woman being given eye drops

Ocuphire’s pupil dilation treatment shows promising Phase III trial results

March 15, 2021
Sales and Marketing Ocuphire, eye treatment, nyxol

Ocuphire Pharma’s Nyxol treatment for pharmacologically-induced pupil dilation (mydriasis) has met its primary and secondary endpoints in its Phase III …

News
The Gateway to Local Adoption Series

Latest content

Alto Neuroscience announces new patent for depression treatment

January 15, 2026

Arkin Capital closes $100m fund for pre-clinical and early clinical-stage biotech

January 15, 2026

Bio-Sourcing and Zerion Pharma receive 1.3m euros in funding for joint breast cancer project

January 14, 2026

Biocartis announces breast cancer research collaboration with US Mayo Clinic

January 14, 2026

Blue Earth announces first UK patient received prostate cancer injection

January 13, 2026